Summary
39 / 100 · Bulios Score
What speaks for it
- It passes 9 of the 9 points of the Piotroski financial health test.
- It has been profitable 5 years in a row.
What to watch
- Earnings per share fell by 44% a year over the last 3 years.
- It pays out more in dividends than it earns: 184% of profit.
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 4.2 years of operating profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 78.9 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 6.1% a year over 5 years. Over the last 3 years it grew by 0.7% a year. Earnings per share fell by 44% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 2.33%
- Paid out of profit
- 184%
You receive $0.21 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.